Trials / Not Yet Recruiting
Not Yet RecruitingNCT07532226
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
A Real-World, Prospective Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Janssen-Cilag Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to assess the 1-year persistence of guselkumab in adult patients with psoriatic arthritis (an inflammatory disease that affects the joints in participants with psoriasis, a skin condition that causes red, scaly patches).
Conditions
Timeline
- Start date
- 2026-04-13
- Primary completion
- 2029-12-03
- Completion
- 2029-12-13
- First posted
- 2026-04-15
- Last updated
- 2026-04-15
Source: ClinicalTrials.gov record NCT07532226. Inclusion in this directory is not an endorsement.